| Literature DB >> 35694295 |
Jorge Pamplona Pagnossa1, Gabriele Rocchetti2, Jadson Diogo Pereira Bezerra3, Gaber El-Saber Batiha4, Eman A El-Masry5,6, Mohamed H Mahmoud7, Abdulrahman A Alsayegh8, Abdullah Mashraqi9, Pier Sandro Cocconcelli2, Cledir Santos10, Luigi Lucini2, Roberta Hilsdorf Piccoli11.
Abstract
Cross-adaptation phenomena in bacterial populations, induced by sublethal doses of antibacterial solutions, are a major problem in the field of food safety. In this regard, essential oils and their major compounds appear as an effective alternative to common sanitizers in food industry environments. The present study aimed to evaluate the untargeted metabolomics perturbations of Salmonella enterica serovar Enteritidis that has been previously exposed to the sublethal doses of the major components of essential oils: cinnamaldehyde, citral, and linalool (CIN, CIT, and LIN, respectively). Cinnamaldehyde appeared to be the most efficient compound in the assays evaluating the inhibitory effects [0.06% (v/v) as MBC]. Also, preliminary tests exhibited a phenotype of adaptation in planktonic and sessile cells of S. Enteritidis when exposed to sublethal doses of linalool, resulting in tolerance to previously lethal concentrations of citral. A metabolomics approach on S. Enteritidis provided an important insight into the phenomenon of cross-adaptation induced by sublethal doses of major compounds of some essential oils. In addition, according to the results obtained, when single molecules were used, many pathways may be involved in bacterial tolerance, which could be different from the findings revealed in previous studies regarding the use of phytocomplex of essential oils. Orthogonal projection to latent structures (OPLS) proved to be an interesting predictive model to demonstrate the adaptation events in pathogenic bacteria because of the global engagement to prevent and control foodborne outbreaks.Entities:
Keywords: bacterial tolerance; biofilm; discriminant analysis; terpenes; untargeted metabolomics
Year: 2022 PMID: 35694295 PMCID: PMC9174793 DOI: 10.3389/fmicb.2022.769110
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 6.064
FIGURE 1Susceptibility (A) and cross-adaptation tests (B) of Salmonella Enteritidis (SE) and Salmonella Typhimurium (ST) against cinnamaldehyde (CIN), citral (CIT), and linalool (LIN). MBC, minimum bactericidal concentration; BMBC, biofilm minimum bactericidal concentration; BMBC-A, biofilm minimum bactericidal concentration of adapted cells.
Spectrophotometric measurements (mean ± standard deviation) of biofilms of S. Enteritidis and S. Typhimurium.
| Biofilm formation in microplate | |||
|
| |||
| Odb | Odnc | Classification | |
| 0.29805 ± 0.05790a | 0.05144 ± 0.00321 | Strong. | |
| 0.14591 ± 0.03349b | 0.05246 ± 0.00648 | Mod. | |
Odb, optical density of biofilm; Odnc, optical density of negative control; Strong., strongly forms biofilms; Mod., moderately forms biofilms. Mean values followed by the same letter do not differ statistically by the Tukey’s test at 5% probability (a and b = between SE and ST).
Spectrophotometric measurements (mean ± standard deviation) of biofilm formation.
| Cinnamaldehyde | Citral | Linalool | |||||||
|
|
|
| |||||||
| Odb | Odcn | Class. | Odb | Odcn | Class. | Odb | Odcn | Class. | |
| 0.5537 ± 0.1187aA | 0.0503 ± 0.0005 | Strong. | 0.4082 ± 0.1051bA | 0.0532 ± 0.0003 | Strong. | 0.4006 ± 0.0850bA | 0.0509 ± 0.0018 | Strong. | |
| 0.1825 ± 0.0491bB | 0.0564 ± 0.0018 | Mod. | 0.2058 ± 0.0397bB | 0.0585 ± 0.0029 | Mod. | 0.3157 ± 0.0267aB | 0.0571 ± 0.0017 | Strong. | |
SE, Salmonella Enteritidis; ST, Salmonella Typhimurium; Odb, optical density of biofilm; Odcn, optical density of negative control; Class., classification; Strong., strongly forms biofilm; Mod., moderately forms biofilm. Mean values followed by the same letter do not differ statistically by the Tukey’s test at 5% probability (a and b = among major compounds; A and B = between SE and ST).
FIGURE 2Heatmap resulting from the average hierarchical clustering considering the different Salmonella Enteritidis treatments. CIN, cinnamaldehyde; CIT, citral; LIN, linalool.
FIGURE 3OPLS-DA of Salmonella Enteritidis treatments. CIN, cinnamaldehyde; CIT: citral; LIN, linalool. R2Y = 0.97; Q2Y = 0.98.
FIGURE 4Classification of VIP markers identified in the compounds of S. Enteritidis by untargeted metabolomics analyses.
FIGURE 5Metabolites involved in the secondary metabolite degradation during S. Enteritidis treatments.